Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The scaffold effectively prevents melanoma relapse and aids wound healing.

Tofacitinib treatment is used for teenagers with alopecia areata.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Ozenoxacin reduces sebum production, helping manage acne.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.